1H-1-Ethyl Candesartan Cilexetil,
914613-35-7,
1-Ethyl-Candesartan Cilexetil,
Candesartan Cilexetil EP Impurity E,
Candesartan cilexetil impurity E [EP],
SCHEMBL14522914,
CTK8E8170,
Candesartan Cilexetil Impurity E,
AKOS027323321,
(+/-)-1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester,
(1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate,
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1-ethyl-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester,
RT-006595,
FT-0668191,
A1-01751,
(RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl-2-ethoxy-1-[[2 inverted exclamation mark -(1-ethyl-1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-benzimidazole-7-carboxylate,
2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester,
UNII-IN72J7R432,
IN72J7R432,
CS-O-07483,